-
6-FAM SE: Reliable Fluorescent Labeling
2026-08-24
A scenario-driven guide to using 6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester), SKU A8771, for more controlled labeling of DNA, proteins, peptides, and assay-tracking reagents. It addresses compatibility, solubility, storage, interpretation, and vendor-selection decisions without presenting the dye as a substitute for validated cell-viability endpoints.
-
Pseudo-UTP: Engineering Better mRNA Translation
2026-08-23
Pseudo-modified uridine triphosphate provides a controllable route to pseudouridine-modified RNA, with implications for RNA stability enhancement, translation performance, and innate immune signaling. This thought-leadership analysis connects Pseudo-UTP chemistry to the translational lessons of a MERS-CoV RBD-mRNA vaccine study while distinguishing product-specific evidence from broader nucleoside-modification principles.
-
Anlotinib Hydrochloride: Assay Workflows
2026-08-22
Build reproducible angiogenesis experiments around Anlotinib hydrochloride, from receptor phosphorylation to endothelial migration and tube formation. This workflow separates pathway-specific anti-angiogenic activity from direct tumor-cell toxicity, helping cancer research teams select informative concentrations and controls.
-
Dacarbazine: From DNA Damage to Translation
2026-08-21
A translational framework for using Dacarbazine with greater mechanistic precision—from DNA alkylation and assay design to regimen context, supportive care, and reproducibility.
-
GSK2606414: A Practical PERK Inhibitor Workflow
2026-08-21
GSK2606414 combines nanomolar PERK potency with strong kinase selectivity, making it useful for separating PERK-dependent unfolded protein response signaling from broader ER-stress effects. This guide translates recent pyroptosis findings into practical workflows for ER stress research, cancer research, and disease-model validation.
-
BRD4-Targeted PROTAC Nanoassemblies Enhance FLASH-RT
2026-08-20
Xu and colleagues developed a folate-targeted, redox-responsive PROTAC nanoassembly that releases ARV-771 inside tumor cells and promotes BRD4 degradation during FLASH radiotherapy. The resulting disruption of BRD4-associated DNA repair, together with increased reactive oxygen species and DNA double-strand breaks, improved tumor cell killing in vitro and in vivo with limited systemic toxicity in the reported preclinical models.
-
ECL Chemiluminescent Substrate Detection Kit Workflow
2026-08-20
Build a sensitive, flexible immunoblot workflow for low-abundance targets using HRP-mediated signal generation on nitrocellulose or PVDF. This guide connects the kit to the urinary nanosensor findings in early atherosclerosis research while clearly separating protein validation from activity-based and diagnostic assays.
-
ZNF263–ULK1 Autophagy Axis in Cholangiocarcinoma
2026-08-19
This study identifies ZNF263 as an oncogenic transcription factor in intrahepatic cholangiocarcinoma (ICC) and links its activity to enhancer-mediated activation of ULK1 and autophagy. By integrating genomic profiling, reporter assays, cellular phenotyping, and xenograft experiments, the authors provide a mechanistic framework for how ZNF263 may support ICC proliferation.
-
Pseudo-UTP for Modified mRNA Synthesis
2026-08-19
Pseudo-UTP enables direct incorporation of pseudouridine into RNA during in vitro transcription, supporting more deliberate studies of RNA persistence, translation, and innate immune recognition. This practical guide covers nucleotide substitution, assay design, quality control, and troubleshooting for mRNA vaccine development and gene therapy RNA modification workflows.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-08-18
This reference study identifies a cell-type-specific circuit mechanism linking Neuroligin 1 loss in dorsal-striatal D2 medium spiny neurons to excessive self-grooming and digging in mice. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the authors implicate D2-MSN hyperactivation and PKC overactivation as mechanistic contributors to autistic-like repetitive behavior.
-
Cabazitaxel (XRP6258): Protocol and QC Guide
2026-08-17
Cabazitaxel (XRP6258) provides a practical taxane workflow for studying microtubule dynamics disruption in taxane-resistant and P-glycoprotein-expressing cancer models. It is intended for DMSO- or ethanol-based research protocols, not aqueous formulations or long-term storage of prepared solutions.
-
Streptavidin-HyperFluor 647 Workflow Guide
2026-08-17
Streptavidin-HyperFluor 647 combines tight biotin recognition with red-range fluorescence for low-background microscopy, flow cytometry, and targeted protein detection. This guide shows how to integrate the Streptavidin fluorescent conjugate into practical assays while distinguishing biotin-based readouts from newer click-compatible proximity-labeling workflows.
-
MTT Assay Workflow for BV2 Neuroinflammation
2026-08-16
Build a practical MTT workflow for measuring BV2 microglial metabolic activity after LPS stimulation and LMTK2 manipulation. This guide separates viability effects from inflammation-linked metabolic shifts, with optimization points for reproducible colorimetric cell viability data.
-
Dehydroepiandrosterone (DHEA) in PCOS and Neuroprotection
2026-08-15
Dehydroepiandrosterone (DHEA) supports distinct workflows for granulosa-cell inflammation studies, neural stem-cell expansion, and excitotoxicity assays. This guide separates DHEA as a mechanistic treatment from its use as a PCOS-modeling stimulus, with practical dosing, solvent, control, and troubleshooting guidance.
-
Oltipraz Workflows for MASLD Nrf2 Studies
2026-08-15
Oltipraz provides a chemically defined Nrf2 and phase II enzyme benchmark for MASLD research, complementing—but not duplicating—the multi-component QSHXO findings. This workflow emphasizes dose control, time-resolved validation, and careful separation of established detoxification biology from testable autophagy and ferroptosis hypotheses.
451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page